Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicenter Randomized Study
暂无分享,去创建一个
T. Similowski | M. Wysocki | J. Timsit | B. Misset | A. Rauss | D. Dreyfuss | Y. Péan | L. Mier | H. Mentec | F. Faurisson | F. Delatour | F. Thomas
[1] R. Gaynes,et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] M. Rybak,et al. Outcome Assessment of Minimizing Vancomycin Monitoring and Dosing Adjustments , 1999, Pharmacotherapy.
[3] Charles G. Martin,et al. Mississippi mud in the 1990s , 1998, Cancer.
[4] M. Rybak,et al. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model , 1997, Antimicrobial agents and chemotherapy.
[5] M. Zeckel. A closer look at vancomycin, teicoplanin, and antimicrobial resistance. , 1997, Journal of chemotherapy.
[6] T. Watanabe,et al. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus. , 1997, The Journal of antimicrobial chemotherapy.
[7] E. Concia,et al. Penetration of vancomycin into human lung tissue. , 1996, The Journal of antimicrobial chemotherapy.
[8] D. Levine,et al. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections , 1996, Antimicrobial agents and chemotherapy.
[9] M. Wysocki,et al. Why monitor peak vancomycin concentrations? , 1995, The Lancet.
[10] N. Saunders. Why monitor peak vancomycin concentrations? , 1994, The Lancet.
[11] D. Rougé,et al. Vancomycine en administration continue chez le grand brûlé. , 1994 .
[12] M. Barclay,et al. Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model , 1994, Antimicrobial Agents and Chemotherapy.
[13] E. Saliba,et al. [Continuous infusion of vancomycin during the neonatal period]. , 1994, Pathologie-biologie.
[14] L. Brinquin,et al. [Continuous infusion of vancomycin in post-neurosurgical staphylococcal meningitis in adults]. , 1993, Presse medicale.
[15] G. Duckworth,et al. Diagnosis and management of methicillin resistant Staphylococcus aureus infection. , 1993, BMJ.
[16] R. Farinotti,et al. Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients , 1993, Antimicrobial Agents and Chemotherapy.
[17] B. R. Reddy,et al. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. , 1991, Annals of internal medicine.
[18] M. Rybak,et al. Nephrotoxicity of vancomycin, alone and with an aminoglycoside. , 1990, The Journal of antimicrobial chemotherapy.
[19] B. Yangco,et al. CDC definitions for nosocomial infections. , 1989, American journal of infection control.
[20] J M Hughes,et al. CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.
[21] B. Estournet,et al. [Ventricular staphylococcal infections. Treatment with vancomycin by continuous venous infusion]. , 1986, Presse medicale.
[22] E. Draper,et al. Prognosis in Acute Organ‐System Failure , 1985, Annals of surgery.
[23] J. L. Gall,et al. A simplified acute physiology score for ICU patients , 1984, Critical care medicine.
[24] J. Turnidge,et al. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. , 1999, The Journal of antimicrobial chemotherapy.
[25] [Antibiogram Committee of the French Society for Microbiology. Official Statement 1999]. , 1999, Pathologie-biologie.
[26] D. Rougé,et al. [Continuous administration of vancomycin in patients with severe burns]. , 1994, Presse medicale.
[27] F. Thomas,et al. Traitement d'infections à staphylocoques chez l'adulte par perfusion veineuse continue de vancomycine en monothérapie , 1988 .
[28] R. Moellering. Pharmacokinetics of vancomycin. , 1984, The Journal of antimicrobial chemotherapy.
[29] Prediction of creatinine clearance. , 1978, American journal of hospital pharmacy.
[30] W. Farrar,et al. ‘VANCOMYCIN REVISITED’ , 1978, Annals of internal medicine.
[31] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .